Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 338, Issue 2, pp 125–132

Transient outward current (IA) in clonal anterior pituitary cells: blockade by aminopyridine analogs

  • Michael A. Rogawski
Article

DOI: 10.1007/BF00174859

Cite this article as:
Rogawski, M.A. Naunyn-Schmiedeberg's Arch Pharmacol (1988) 338: 125. doi:10.1007/BF00174859

Summary

Whole cell voltage-clamp recordings from GH3 cells, a clonal cell line derived from a rat anterior pituitary tumor, demonstrated a rapidly activating and inactivating (“transient”) voltage-dependent outward current. This current, referred to as IA, was elicited by step depolarization from holding potentials negative to −50 mV, showed strong outward rectification at potentials positive to −30 mV, and exhibited steady state inactivation with V1/2 near −64 mV. The current rose to a peak within < 10–20 ms following depolarization and decayed in two exponential phases, IAf and IAAS with time constants of 30–50 and 500–700 ms, respectively. Both IA components exhibited similar voltage dependencies for activation and inactivation. Aminopyridines (2 μmol/l − −5 mmol/l) produced a dose dependent, reversible blockade of IA (70% inhibition at 0.5 to 2 mmol/l) with the following rank order of potencies: 4-aminopyridine > 3,4-diaminopyridine = 3-aminopyridine > 2-aminopyridine. These drugs reduced the peak conductance of IA, and produced complex effects on its time-dependent decay. With submaximal degrees of block, there was an increase in the inactivation rate, suggesting that open channels are preferentially blocked by the drugs. It is concluded that GH3 pituitary cells possess an aminopyridine-sensitive transient outward current comparable to the A-current in neural cells. However, this cell line is unusual in that it expresses both rapidly and slowly decaying A-current components.

Key words

A-current Potassium current Aminopyridine Anterior pituitary tumor cells Whole cell voltage clamp 

Abbreviations

n-AP

n-aminopyridine

3,4-DAP

3,4-diaminopyridine

TEA

tetraethylammonium

EGTA

ethylene glycol bis(β-aminoethyl ether)N,N′-tetraacetic acid

HEPES

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Michael A. Rogawski
    • 1
  1. 1.Medical Neurology BranchNational Institute of Neurological and Communicative Disorders and Stroke, National Institutes of HealthBethesdaUSA